Open AccessA Patient Care Program for Adjusting the Autoinjector Needle Depth According to Subcutaneous Tissue Thickness in Patients With Multiple Sclerosis Receiving Subcutaneous Injections of Glatiramer Acetate
Author(s) -
Maria Luisa Sánchez Masid,
Rosalía Horno Ocaña,
Miguel Gil Gil,
Maria Tereza de Oliveira Ramos,
Miguel Roig,
Mario Carreño,
Julia Morales,
Manuel Carrasco,
Lisandro Carralero Hidalgo,
Ana Maria Bernad Felices,
Adela Harto Castaño,
Purificación Castañeda Romero,
P. Martínez,
Rainel Sánchez-de la Rosa
Publication year - 2015
Publication title -
the journal of neuroscience nursing/journal of neuroscience nursing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.371
H-Index - 43
eISSN - 1945-2810
pISSN - 0888-0395
DOI - 10.1097/jnn.0000000000000086
Subject(s) - medicine , buttocks , injection site , visual analogue scale , subcutaneous injection , subcutaneous tissue , multiple sclerosis , glatiramer acetate , anesthesia , surgery , biomedical engineering , psychiatry
The perceived pain on injection site caused by subcutaneous (SC) self-injection may negatively affect acceptance and adherence to treatment in patients with multiple sclerosis (MS). Pain on injection may be caused by inaccurate injection technique, inadequate needle length adjustment, or repeated use of the same injection body area. However, information is lacking concerning the optimal needle depth to minimize the injection pain.